Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. - Wikidata - wikimedia - TriplyDB

Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.

Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.

http://www.wikidata.org/entity/Q38351966

about

Regulation of synthesis and roles of hyaluronan in peritoneal dialysis Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment Graves' ophthalmopathy Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17 Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease.Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody.Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.Advances in the management of thyroid eye disease Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.A modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by Graves' disease orbital cells.Pathogenesis of Graves' orbitopathy: a 2010 update.Hyaluronan synthase 1: a mysterious enzyme with unexpected functions Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.News and views: at long last, an animal model of Graves' orbitopathy.Anatomical, Physiological, and Functional Diversity of Adipose Tissue.Preoperative clinical features of reactivated of Graves' orbitopathy after orbital decompression.

P2860

Q26778414-48B5F153-148C-4162-99F5-01C07F6500A2 Q27005680-E9017085-23D2-4B9F-8A20-8D17958ABBD9 Q28274196-BE64654F-164A-4F53-9F91-36165BCB3FC0 Q28730668-914A294E-3E6B-41C7-8795-52014E1AD4C7 Q35085196-69A29202-96EA-434F-874B-E9ADA80214CC Q35153361-8EFB07B7-098E-4E10-8695-C72D4AD2A6D3 Q35921348-F6A0896C-5094-49DB-A9C9-2FD580EE7295 Q35992560-380E7CDF-D74B-444A-BDEF-9AAF76C5BD1F Q36108611-61613750-8A2B-46DA-AE83-0A3F36B1405A Q36124305-AAF8BDA3-BBBC-47AC-BC1E-88C5E8EEFAC6 Q36393011-67434199-5EAD-4831-90DC-1C53F1B177B5 Q36817224-5113CC9D-4D0E-46FD-86E1-390F27270A1A Q36965291-AFB9F15C-B98A-406C-BBDB-61B3153C726C Q37012076-A3A41576-8A4C-46D8-B689-7241A03AD409 Q37017174-3CD1168F-59A4-4A97-8DAA-847464DF2D91 Q37404274-BC03C5BC-A2F0-4445-A505-95F3D3664514 Q37479329-30854634-CDDF-474D-AC4F-852F47CA27D4 Q37772737-A60BF2E5-0E30-4B59-AC02-C697A702542A Q38362645-0E69CB75-9BD3-41D3-96D8-5636BFBE6E46 Q38633022-7B150A1A-FD57-4E96-9DF0-149AE09F2B7D Q42562858-FA013F27-3EDB-43C2-B017-AF6FE69E5174 Q50103146-D2A7A3AF-657C-4E9F-81D1-752B99187AF5 Q50967696-326AF1F5-3AD7-4C5F-BA98-C1AE52C380E0

P2860

Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.

http://www.wikidata.org/entity/Q38351966

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Thyrotropin receptor activatio ...... lation in thyroid dysfunction.

@en

type

label

Thyrotropin receptor activatio ...... lation in thyroid dysfunction.

@en

prefLabel

Thyrotropin receptor activatio ...... lation in thyroid dysfunction.

@en

P1433

Q38351966-18B718FD-1046-407D-BAAB-C0EBD2800420

P1476

Q38351966-00B43489-32E7-4FFB-B433-3687F38698A8

P2093

Q38351966-1303BEFC-50F6-4DCE-B0EF-3932E67893FF

Q38351966-29FE07AD-0D7A-4712-99CD-FD572CBEBCB3

Q38351966-4B166ADC-B7F0-4A01-B4F6-D3306ACA73A9

Q38351966-84D9D17B-90AC-40C1-B5BF-D099706C8951

Q38351966-F7E30B5C-D14B-42CF-B433-57CCF9D828F2

P2860

Q38351966-0755E3E0-DACF-4AD0-AC89-CA9C14403B3B

Q38351966-16BB96B5-1BDB-4A44-BED7-A479D5025D72

Q38351966-19BDBFCD-AE09-411E-9B7A-C2550776D7B2

Q38351966-1B43A791-5099-4C3A-BE0F-795F10D8BED4

Q38351966-217A539E-10CA-4E56-9759-C02908CEB737

Q38351966-2A8B59F0-8A24-46E1-B89F-C08ED1D14A15

Q38351966-388E99E9-0668-48D6-A12C-1CF5D3F9D905

Q38351966-3A8F5958-0F65-468A-AE0B-9405574D3C78

Q38351966-3B6A025D-2DA0-4830-B7D6-EFFA5C5375E7

Q38351966-4439B525-E887-4EEB-9546-D4615B9216DF

P304

Q38351966-5644DB13-7B5D-40C1-9684-46EE40E0A18E

P31

Q38351966-94CEAA82-2E4A-4A10-A7E5-B46AD908380A

P356

Q38351966-F4A4789B-916B-48AE-AF94-269E09A6B45B

P407

Q38351966-908DCAC9-1878-4DE7-ADE2-6BFD1D8E7A12

P433

Q38351966-7487F55F-8ECC-4A05-83CE-94E082E057BC

P478

Q38351966-5B52F2C7-74F5-4142-A480-9C2FFF9118D4

P50

Q38351966-374C3450-A46B-4CB7-B780-4750E5630435

Q38351966-917B385C-60D6-4E49-BFC0-598ADF1F1CCA

Q38351966-B939C34A-E119-4BDD-8789-13AA7731F19E

P577

Q38351966-01DC2399-94D9-4A28-8BEF-B22D12BA0941

P698

Q38351966-AEE31B8C-FBEC-447E-B133-F4A1854A5D55

P932

Q38351966-3D5B5872-2351-44A1-9962-7A5BE08A760F

P356

JBC.M109.003616

P1433

Journal of Biological Chemistry

P1476

Thyrotropin receptor activatio ...... ulation in thyroid dysfunction

@en

P2093

Carol Paddon

http://www.w3.org/2001/XMLSchema#string

Fiona Grennan-Jones

http://www.w3.org/2001/XMLSchema#string

Peter Giles

http://www.w3.org/2001/XMLSchema#string

Robert Steadman

http://www.w3.org/2001/XMLSchema#string

Timothy Bowen

http://www.w3.org/2001/XMLSchema#string

P2860

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties

MatInspector and beyond: promoter analysis based on transcription factor binding sites

A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes

The Thyrotropin Receptor and the Regulation of Thyrocyte Function and Growth*

Signaling properties of hyaluronan receptors.

Involvement of hyaluronan in regulation of fibroblast phenotype.

Connective tissue, glycosaminoglycans, and diseases of the thyroid.

Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan

Effects of adenosine 3':5'-cyclic monophosphate and serum on synthesis of hyaluronic acid in confluent rat fibroblasts.

Extrathyroidal complications of Graves' disease.

P304

26447-26455

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M109.003616

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19633293

http://www.w3.org/2001/XMLSchema#string

P932

2785333

http://www.w3.org/2001/XMLSchema#string